The Clinical Neurosciences Group of IRBLleida presents their results on stroke research at the Second Congress of the European Society of Stroke

Lleida, May 18, 2016 The Group of Clinical Neurosciences from the Institute of Biomedical Research Lleida- Dr. Pifarré Foundation (IRBLleida) presented their results on stroke research carried out in Lleida at the 2nd ESOC, which took place from 10 to 12 May in Barcelona. The Group contributed with seven poster presentations and an oral communication given by the principal investigator, Francisco Purroy. Dr. Purroy spoke about a meta-analysis performed to evaluate the risk of early stroke after a transient ischemic attack (TIA; a brief loss or reduction of cerebral blood flow). After analysing thirteen publications (adding a total of 10,341 patients) he came to the conclusion that the risk of stroke after a TIA is always reduced when a strategy of emergency care is applied to patients. The European Stroke Organisation Conference is the largest European congress in its field, attended by 3,500 professionals from around the world, and covers both, the clinical (diagnosis and treatment of patients) and the basic (cellular and animal models) stroke research sides. At the poster session Ana Vena presented a study about the incidence and trends of stroke in Lleida on the last four years, and another on clinical evolution of stroke in function of their age, this last study complements the poster presented by Francisco Purroy about the effectiveness of thrombolytic therapy in over 80 ictus patients. Regarding the basic research, Serafí Cambray presented a study performed in mice model that allowed identifying molecules that detect the elapsed time after stroke and new neuroprotective genes to mitigate stroke damage. The Clinical Neurosciences also counts with PhD students that also presented their works: one about the detection of a type of cardiac arrhythmia that increases fivefold stroke risk (Jessica Molina), another analysing the neuropsychological profile in TIA patients (Anna Carnés), and finally Laura Colàs presented a study about genetic variations that predispose to early stroke while receiving anticoagulants treatment.